Literature DB >> 10609210

Long-term results of combined 1-way phacoemulsification, intraocular lens implantation, and trabeculectomy.

A Caporossi1, F Casprini, G M Tosi, A Balestrazzi.   

Abstract

PURPOSE: To analyze the results of 1-way phacoemulsification and posterior chamber intraocular lens (IOL) implantation combined with trabeculectomy.
SETTING: Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy.
METHODS: This retrospective study comprised 42 eyes of 36 patients with glaucoma and cataract who had phacoemulsification with posterior chamber IOL implantation combined with trabeculectomy. The mean follow-up of 28.24 months +/- 10.99 (SD) (range 11 to 52 months) included measurement of intraocular pressure (IOP), visual acuity, visual field, endothelial cell loss, and notation of complications.
RESULTS: There was a statistically significant postoperative improvement in visual acuity (P < .001). Mean preoperative best corrected visual acuity (BCVA) was 20/200 (range 20/30 to hand movements). Mean 1 year postoperative BCVA was 20/30 (range 20/20 to 20/60). The preoperative mean IOP of 24.06 mm Hg decreased to 15.36 mm Hg at 1 year (P < .001). All 42 eyes had a postoperative IOP of less than 21.00 mm Hg. Mean central cornea endothelial cell density preoperatively was 2238 +/- 396 cells/mm2 (range 1697 to 2906 cells/mm2) and postoperatively, 2005 +/- 397 cells/mm2 (range 1302 to 2801 cells/mm2). Early postoperative complications consisted of a choroidal detachment in 2 patients (4.76%). Three and 4 days after surgery, respectively, 2 patients (4.76%) had surgery to remove viscoelastic substance under the IOL. Late complications included posterior synechias in 3 eyes (7.14%). One year after surgery, because of a significant decrease in vision, a neodymium:YAG laser posterior capsulotomy was necessary in 2 eyes, 1 with an acrylic IOL (3.70%) and 1 with a silicone lens (9.09%).
CONCLUSION: Combined phacoemulsification, posterior chamber IOL implantation, and trabeculectomy was safe and effective in patients with coexisting glaucoma and cataract.

Entities:  

Mesh:

Year:  1999        PMID: 10609210     DOI: 10.1016/s0886-3350(99)00269-2

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  5 in total

1.  Changes in axial length following trabeculectomy and glaucoma drainage device surgery.

Authors:  B A Francis; M Wang; H Lei; L T Du; D S Minckler; R L Green; C Roland
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

2.  A randomized prospective study comparing trabeculectomy with and without the use of a new removable suture.

Authors:  A Caporossi; A Balestrazzi; A Malandrini; G M Tosi; T Caporossi; P Frezzotti; Luca Lomurno
Journal:  Int Ophthalmol       Date:  2008-06-14       Impact factor: 2.031

3.  Corneal endothelial cell loss after trabeculectomy or after phacoemulsification, IOL implantation and trabeculectomy in 1 or 2 steps.

Authors:  María I Soro-Martínez; María P Villegas-Pérez; Paloma Sobrado-Calvo; José M Ruiz-Gómez; Jaime Miralles de Imperial Mora-Figueroa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-16       Impact factor: 3.117

4.  Insertion of a foldable hydrophobic IOL through the trabeculectomy fistula in cases with microincision cataract surgery combined with trabeculectomy.

Authors:  Tanuj Dada; Rajamani Muralidhar; Harinder S Sethi
Journal:  BMC Ophthalmol       Date:  2006-03-19       Impact factor: 2.209

5.  Corneal endothelial cell loss after trabeculectomy and phacoemulsification in one or two steps: a prospective study.

Authors:  María Isabel Soro-Martínez; Juan Antonio Miralles de Imperial-Ollero; Miriam Pastor-Montoro; Gabriel Arcos-Villegas; Paloma Sobrado-Calvo; José María Ruiz-Gómez; Jaime Miralles de Imperial-Mora-Figueroa; María Paz Villegas-Pérez
Journal:  Eye (Lond)       Date:  2021-01-07       Impact factor: 3.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.